Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | FTH1 | P02794 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | PTAFR | P25105 | 2/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14087223 | 0.95 | — | — | |
| SCHEMBL7108599 | 0.95 | — | — | |
| SCHEMBL1262673 | 0.95 | — | — | |
| SCHEMBL19256280 | 0.93 | — | — | |
| Methyl Alcohol SCHEMBL3833898 | 0.91 | CYP3A4 (0.43) | CYP3A4ALDH1A1FTH1CYP2C9CYP2C19 | |
| SCHEMBL55792 | 0.87 | — | — | |
| SCHEMBL15471499 | 0.87 | — | — | |
| SCHEMBL11177573 | 0.76 | CYP3A4 (0.55) | CYP3A4ALDH1A1FTH1CYP2C9CYP2C19 | |
| SCHEMBL15484174 | 0.73 | — | — | |
| SCHEMBL3879309 | 0.71 | CYP3A4 (0.36) | CYP3A4ALDH1A1FTH1CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1384737-B1 | Cycloaliphatic epoxy compounds containing styrenic functionality | NAT STARCH CHEM INVEST (US) | 2008-11-12 | — | — | EP | disclosed |
| CN-100430400-C | Cyclic-aliphatic epoxy compound containing pheneylethylene cinnamyl or maleimide functional group | NAT STARCH CHEM INVEST (US) | 2008-11-05 | — | — | CN | disclosed |
| EP-1531166-A2 | Cycloaliphatic epoxy compounds containing styrenic, cinnamyl, or maleimide functionality | National Starch and Chemical Investment Holding Corporation (US) | 2005-05-18 | — | — | EP | disclosed |
| CN-1488631-A | Cyclic-aliphatic epoxy compound containing pheneylethylene cinnamyl or maleimide functional group | ���ҵ�ۼ���ѧͶ�ʿعɹ�˾ | 2004-04-14 | — | — | CN | disclosed |
| US-6716992-B2 | FREE RADICAL CURABLE; ADHESIVES | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION | 2004-04-06 | — | — | US | disclosed |
| EP-1384737-A2 | Cycloaliphatic epoxy compounds containing styrenic, cinnamyl, or maleimide functionality | National Starch and Chemical Investment Holding Corporation (US) | 2004-01-28 | — | — | EP | disclosed |
| US-20040014890-A1 | CYCLOALIPHATIC EPOXY COMPOUNDS CONTAINING STYRENIC, CINNAMYL, OR MALEIMIDE FUNCTIONALITY | HENKEL AG & CO. KGAA (DE) | 2004-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040014890-A1 | CYCLOALIPHATIC EPOXY COMPOUNDS CONTAINING STYRENIC, CINNAMYL, OR MALEIMIDE FUNCTIONALITY | GABRE, MEP1B, GABRD | CYP3A4 501/4885ALDH1A1 2514/4885FTH1 2136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.